Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
CAS No. ———
1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside( ——— )
Catalog No. M38303 CAS No. ———
1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief Description1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
-
Description1,2,3,4-Tetrahydroxy-2-methylbutane-1-O-trans-caffeoyl-4-O-β-D-glucopyranoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WKYMVM 2TFA(187986-1...
WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells.Using blood samples withdrawn from 28 AL patients and 31 healthy controls, found that, in the absence of exogenous WKYMVm, WKYMVm receptor and bactericidal activity did not differ between patients and controls.?
-
Total ginkgolic acid
Total ginkgolic acid
-
NorA-IN-1
NorA-IN-1 is a NorA efflux inhibitor, which can be used to study overcoming multidrug resistance based on microbial efflux transporter proteins.
